一次性输尿管镜市场- 按产品（软性输尿管镜、硬性输尿管镜）、按应用（尿石症、尿道狭窄、肾癌）、按最终用途（医院、门诊手术中心）和全球预测（2024 - 2032 ）

在严格的感染控制监管标准的带动下，一次性输尿管镜市场规模预计从 2024 年到 2032 年将以 17% 的复合年增长率扩大。一次性输尿管镜旨在最大程度地减少交叉污染的风险，并透过消除使用之间的再处理需求来简化手术过程。

医院和诊所正在采用这些设备来满足不断发展的标准并提高患者的安全。越来越多地采用先进材料和设计创新来降低感染风险并提高性能，这将进一步增加产品需求。例如，2024 年 4 月，奥林巴斯宣布 FDA 批准 RenaFlex™，这是首款抛弃式输尿管软镜，可解决感染控制问题，同时提高手术效率。

整个市场分为产品、应用、最终用途和地区。

根据应用情况，预计从2024 年到2032 年，肾癌领域的一次性输尿管镜市场价值将大幅增长。风险。外科医生正在利用一次性输尿管镜以更高的安全性和效率来接近和治疗肿瘤，同时避免与重新处理可重复使用的镜相关的复杂性。此外，快速发展有助于肾癌治疗，减少手术时间并提高患者治疗效果。

预计到2032 年，门诊手术中心(ASC) 最终用途领域的一次性输尿管镜行业将以复合年增长率大幅扩张。和病人安全。这些中心正在采用内视镜技术的最新进展，以简化手术流程并降低交叉污染的风险。这项发展进一步推动 ASC 更广泛地采用一次性设备，以优化操作工作流程并改善患者的整体治疗效果。

从地区来看，由于医疗保健的扩张和泌尿系统疾病盛行率的上升，预计欧洲一次性输尿管镜市场规模将在 2024 年至 2032 年间大幅增加。医疗机构正在整合一次性输尿管镜，以满足对有效、卫生的诊断工具不断增长的需求。这些一次性设备为管理泌尿系统健康提供了更安全、更有效的解决方案，并支持更好的患者治疗结果并简化了该地区的程序实践。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

• 产业生态系统分析
• 产业影响力
  • 成长动力
    • 胃肠道疾病、癌症和其他慢性病的发生率上升
    • 一次内视镜的技术进步
    • 微创手术的需求不断增加
  • 产业陷阱与挑战
    • 输尿管镜手术费用高
• 成长潜力分析
• 报销场景
• 监管环境
• 技术景观
• 未来市场趋势
• 价值链分析
• 差距分析
• 波特的分析
• PESTEL分析

第 4 章：竞争格局

• 介绍
• 公司市占率分析
• 公司矩阵分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 战略仪表板

第 5 章：市场估计与预测：按产品分类，2021 - 2032 年

• 主要趋势
• 输尿管软镜
• 硬性输尿管镜

第 6 章：市场估计与预测：按应用分类，2021 - 2032

• 主要趋势
• 尿路结石
• 尿道狭窄
• 肾癌
• 其他应用

第 7 章：市场估计与预测：按最终用途，2021 - 2032 年

• 主要趋势
• 医院
• 门诊手术中心 (ASC)
• 其他最终用户

第 8 章：市场估计与预测：按地区，2021 - 2032

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
  • 欧洲其他地区
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
  • 亚太地区其他地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地区
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋
  • 中东和非洲其他地区

第 9 章：公司简介

• AED.MD
• Becton, Dickinson and Company
• Boston Scientific Corporation
• Coloplast
• Cook Medical
• Dornier MedTech
• Karl Storz GmbH
• NeoScope Inc.
• Olympus Corporation
• OPCOM
• Richard Wolf GmbH
• Zhuhai Pusen Medical Technology Co., Ltd.

Disposable Ureteroscope Market size is projected to expand at 17% CAGR from 2024 to 2032, led by stringent regulatory infection control standards. Disposable ureteroscopes are designed to minimize the risk of cross-contamination and streamline the surgical process by eliminating the need for reprocessing between uses.

Hospitals and clinics are adopting these devices to meet the evolving standards and enhance patient safety. Rising incorporation of advanced materials and design innovations to reduce infection risks and improve performance will further add to the product demand. For instance, in April 2024, Olympus announced FDA clearance for RenaFlex(TM), the first single-use flexible ureteroscope that addresses infection control concerns while enhancing procedural efficiency.

The overall market is segregated into product, application, end-use, and region.

Based on application, the disposable ureteroscope market value from the kidney cancer segment is estimated to rise at significant rate from 2024 to 2032. These devices are integrated into medical procedures to enhance precision and minimize infection risks due to their single-use designs. Surgeons are utilizing disposable ureteroscopes to access and treat tumors with greater safety and efficiency whilst avoiding the complexities associated with reprocessing reusable scopes. In addition, rapid developments are helping in kidney cancer treatment for reducing procedure times and enhancing patient outcomes.

Disposable ureteroscope industry from the ambulatory surgical centers (ASCs) end-use segment is anticipated to expand at substantial CAGR up to 2032. This is owing to the increasing adoption of disposable ureteroscopes in these settings to enhance procedural efficiency and patient safety. These centers are incorporating the latest advancements in endoscopic technology to streamline surgical processes and reduce the risk of cross-contamination. This evolution is further driving ASCs towards adopting single-use devices more widely for optimizing operational workflows and improving overall patient outcomes.

Regionally, the Europe disposable ureteroscope market size is projected to depict immense growth between 2024 and 2032, on account of healthcare expansion and the rising prevalence of urological conditions. Healthcare facilities are integrating disposable ureteroscopes to address the growing demand for effective and hygienic diagnostic tools. These single-use devices are providing safer and more efficient solutions for managing urological health and supporting better patient outcomes and streamlined procedural practices in the region.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising incidences of gastrointestinal disorders, cancer, and other chronic conditions
    • 3.2.1.2 Technological advancements in disposable endoscopes
    • 3.2.1.3 Increasing demand for minimally invasive procedures
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High cost of ureteroscopy procedures
• 3.3 Growth potential analysis
• 3.4 Reimbursement scenario
• 3.5 Regulatory landscape
• 3.6 Technological landscape
• 3.7 Future market trends
• 3.8 Value chain analysis
• 3.9 GAP analysis
• 3.10 Porter's analysis
• 3.11 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Flexible ureteroscope
• 5.3 Rigid ureteroscope

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Urolithiasis
• 6.3 Urethral stricture
• 6.4 Kidney cancer
• 6.5 Other applications

Chapter 7 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Ambulatory surgical centers (ASCs)
• 7.4 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
  • 8.3.7 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
  • 8.5.4 Rest of Latin America
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE
  • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

• 9.1 AED.MD
• 9.2 Becton, Dickinson and Company
• 9.3 Boston Scientific Corporation
• 9.4 Coloplast
• 9.5 Cook Medical
• 9.6 Dornier MedTech
• 9.7 Karl Storz GmbH
• 9.8 NeoScope Inc.
• 9.9 Olympus Corporation
• 9.10 OPCOM
• 9.11 Richard Wolf GmbH
• 9.12 Zhuhai Pusen Medical Technology Co., Ltd.